Enico

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Enico

What is Enico?

Enico is a pharmaceutical preparation containing the active substance entecavir. It belongs to a class of medications known as nucleoside analogues. This medication is designed to address chronic hepatitis B virus (HBV) infection in the body.

Mechanism of Action

The primary function of Enico is to inhibit the replication of the hepatitis B virus. It achieves this by interfering with the viral enzyme called reverse transcriptase. By blocking this enzyme, the medication reduces the ability of the virus to multiply and infect new liver cells. This process helps to lower the amount of virus present in the bloodstream, commonly referred to as the viral load.

Therapeutic Purpose

Enico is used as a long-term management strategy for chronic hepatitis B. The goal of treatment is to:

  • Decrease the levels of HBV DNA in the body.
  • Reduce the inflammation and damage to the liver caused by the persistent viral infection.
  • Improve the histological condition of the liver, which can prevent the progression of liver scarring or other complications related to chronic infection.

While Enico helps control the virus, it is important to understand that it is not a cure for hepatitis B. It does not eliminate the virus from the body entirely but rather manages the infection to maintain liver health and prevent further progression of the disease.

What side effects are possible with Enico?

Possible Side Effects and Safety Information

The official safety profile for Enico (Alpha-Tocopherol) is based on regulatory documents from health authorities such as the FDA and EMA. Adverse reactions are grouped by system-organ class and frequency, often linked to higher dosage and prolonged use.


Officially Documented Adverse Reactions

Classification Examples of Reactions
Common Diarrhea, often associated with doses greater than 400 IU daily.
Uncommon Headache, fatigue (asthenia), dizziness, and dermatological effects such as rash or alopecia.
System-Organ Classes Gastrointestinal disorders, general disorders, nervous system disorders, and skin/subcutaneous tissue disorders are commonly involved.

Serious Safety Considerations

The most critical safety statement across regulatory documents relates to the potential for increased bleeding tendency or hemorrhage, which is documented with the prolonged use of very high doses (e.g., above 1,000 mg or 1,490 IU daily). This effect is also associated with an increased risk of hemorrhagic stroke in susceptible populations.

Population-Specific Constraints

The official safety documents advise caution and monitoring of the International Normalized Ratio (INR) for individuals concurrently taking oral anticoagulants (e.g., warfarin). Caution is also advised for patients with pre-existing Vitamin K deficiency or those with a history of bleeding disorders, as high doses may exacerbate these conditions. High-dose supplementation is generally recommended to be discontinued prior to surgical procedures.

Overdose and Emergency Response

Overdose Manifestations and Risks

Official regulatory documents state that overexposure to Alpha-Tocopherol may present with non-life-threatening clinical manifestations, including gastrointestinal signs such as nausea, diarrhea, abdominal pain, or stomach cramps. Systemic effects may involve muscle weakness, fatigue, and headache.

The most significant documented risk associated with chronic, high-dose ingestion (typically above 1,000 mg daily) is bleeding (hemorrhage), which can escalate to serious outcomes like intracranial hemorrhage. Population-specific warnings note that patients taking anticoagulant or antiplatelet medications are at a heightened risk for this severe complication. The product is also noted to carry a specific risk of overdose in infants.

When to Seek Immediate Medical Help

The primary mandated action in a suspected overdosage is the immediate discontinuation of the supplement and a requirement to seek professional medical assistance.

Urgent medical attention is required for severe presentations. Regulators mandate that emergency services must be contacted immediately if the individual has collapsed, is having a seizure, is experiencing difficulty breathing, or cannot be awakened.

Management protocols focus on supportive care and the cessation of the vitamin. In cases where significant bleeding is present, consideration for Vitamin K supplementation may be required, alongside monitoring of blood clotting factors.

Therapeutic Uses of Enico

What Enico Treats: Main Uses and Benefits

Enico is used to address specific health issues primarily related to its role as an essential nutrient. The primary therapeutic domain is for managing Vitamin E deficiency stemming from chronic malabsorption disorders, such as Cystic Fibrosis, or typically in specific rare genetic diseases. The therapy is relevant in contexts marked by increased discomfort or tension resulting from nutrient shortfall.


Therapeutic Focus and Symptom Support

The medication is considered relevant for addressing the associated neurological and muscular impairments that result from long-term deficiency. These challenging symptoms include loss of feeling in limbs (peripheral neuropathy), generalized muscle weakness, and problems with movement control like ataxia (difficulty with coordination). Enico is also applied as a supportive agent in managing symptoms for select chronic conditions, which may include assisting with Age-Related Macular Degeneration (AMD) and contributing to maintaining functional stability in cases of mild to moderate Alzheimer's disease.

“The supportive relief offers symptomatic assistance, helping patients cope more steadily with symptom fluctuations caused by nutrient shortfall.”

Quick Fact: Deficiency and Neurological Support

Enico is commonly used to help manage Vitamin E deficiency and the associated severe neurological and muscular deficits (ataxia, peripheral neuropathy) that arise from established, chronic nutrient shortfall.

Eligibility and Restrictions for Use

Eligibility for Enico (Alpha-Tocopherol)

The criteria for using Enico, which contains high-dose Alpha-Tocopherol (Vitamin E), are strictly defined by regulatory health authorities and depend on specific patient populations and existing medical conditions.


Populations Allowed and Contraindicated

Classification Population/Condition
Use is Allowed Adults, children, and infants with Vitamin E deficiency, particularly those due to fat malabsorption disorders (e.g., Cystic Fibrosis).
Use is Contraindicated Patients with known hypersensitivity to Alpha-Tocopherol or excipients.
Use is Contraindicated Patients with Vitamin K deficiency or certain rare hereditary sugar intolerances.

Restrictions and Conditional Use

Age and Physiological Status:

High-dose use is not recommended in low birth weight premature infants due to documented risks. During pregnancy and lactation, use is generally acceptable as an essential nutrient, but high doses should only be taken if prescribed.

Condition-Based Restrictions:

Extreme caution is required in patients with pre-existing bleeding disorders (such as hemorrhagic stroke or hemophilia) or those concurrently taking oral anticoagulants (e.g., warfarin). The official label also specifies that high-dose supplementation should be stopped approximately one month prior to scheduled surgery.

What should I know about interactions with other medicines?

The official interaction profile for Alpha-Tocopherol (Enico) is defined primarily by its impact on blood coagulation and its dependence on fat absorption.

Pharmacodynamic Potentiation of Anti-Clotting Agents

Alpha-Tocopherol, particularly when taken at high doses, carries a risk of pharmacodynamic potentiation when co-administered with certain medications. This interaction may increase the likelihood of hemorrhage.

  • Anticoagulants: The medication may potentiate the effect of blood thinners, such as Warfarin, by exhibiting anti-vitamin K activity, necessitating careful monitoring.
  • Antiplatelet Agents: Co-administration with antiplatelet drugs, including Aspirin and Clopidogrel, may similarly heighten the documented risk of bleeding. This potentiation also extends to certain herbal products with antithrombotic activity, such as garlic and ginkgo.

Absorption and Administration-Timing Rules

Alpha-Tocopherol’s absorption can be significantly impacted by medicines that interfere with the uptake of dietary fat. Conversely, Alpha-Tocopherol can affect the absorption of other compounds.

  • Reduced Alpha-Tocopherol Exposure: Drugs that inhibit fat absorption, such as Orlistat, Bile Acid Sequestrants (e.g., Cholestyramine), mineral oil, and Sucralfate, may result in decreased Alpha-Tocopherol levels.
  • Mandatory Timing: A specific administration timing rule applies to Orlistat: the oral softgel must be taken two hours before or two hours after Orlistat to mitigate reduced absorption.
  • Reduced Exposure of Other Drugs: Alpha-Tocopherol may also decrease the systemic exposure of oral ferric iron salts by inhibiting their gastrointestinal absorption.

Mechanism of Action

Enico (Alpha-Tocopherol) exerts its action by becoming an integral functional component of the cell's structural machinery, focused on modulating cellular integrity within the lipid phase of the body. The molecule functions as a chain-breaking antioxidant by neutralizing destructive lipid peroxyl radicals ( ROO^bullet) and stabilizing Polyunsaturated Fatty Acids (PUFAs). The donation of a hydrogen atom terminates the lipid peroxidation cascade, leading to the cessation of the uncontrolled spread of damage within the cell membranes and resulting in a less reactive cellular environment.

The direct consequence of this scavenging action is the maintenance of the structural integrity and optimal fluidity of the lipid bilayer. This mechanism contributes to maintaining the basic functionality and appropriate barrier role of cell membranes across all body systems, which is essential for preserving the structural integrity of cells, including the stabilization of erythrocyte structure. Beyond this, the molecule modulates specific intracellular signaling pathways, including the activity of NF-kB and Protein Kinase C (PKC). By influencing these regulatory factors, the mechanism mediates the attenuation of certain inflammatory signals, thereby influencing the cellular redox state.

Dosage and Administration Information

How to Use Enico

This section outlines the administration instructions and standard dosing principles for Enico, focusing strictly on procedural usage.


Administration Scope

Feature Guideline
Route of administration Oral is the standard method for all available formulations, including softgel capsules, tablets, and solutions.
Dosing schedule (Adults) Maintenance: The daily allowance is 15 mg alpha-tocopherol. General Deficiency: Standard doses typically fall between 60 and 75 International Units (IU) daily. Maximum Limit (UL): The established upper intake level for adults is 1000 mg alpha-tocopherol per day.
Timing in relation to meals Administration must occur with a meal that contains fat (a lipid-based meal). This condition is required to ensure proper systemic absorption of the fat-soluble vitamin.
Age-group rules Dosing for children is weight- and age-based, with specific guidelines defining adjusted allowances for pediatric groups.
Special handling Oral softgel capsules and certain tablets must be swallowed whole; they are not to be crushed, cut, or chewed to preserve the integrity of the delivery system.

Usage Protocol Structure

Procedural steps:

  • The appropriate daily dosage, which varies between the maintenance amount and the therapeutic range, is determined according to specific use-cases.
  • The oral dosage form is administered once daily (qDay), which is the standard frequency for this preparation.
  • The medicine must be ingested concurrently with a fat-containing meal to satisfy the required condition for absorption.
  • The oral capsule or tablet must be swallowed whole to ensure proper delivery.

Connection to the overall use protocol:

These instructions define a standardized administration method, linking the once-daily oral delivery directly to the prerequisite of consuming the dose with a fatty meal. This context-of-use ensures the preparation's compliance with its inherent fat-soluble properties, supporting its intended therapeutic and maintenance role.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Studies

Research has explored the compound Enico primarily in the context of chronic inflammatory conditions, with a focus on Rheumatoid Arthritis (RA). Studies evaluated the use of this compound concerning symptoms and signs associated with inflammation, such as changes in joint pain levels and laboratory markers.

Detailed Findings in Rheumatoid Arthritis

Clinical trials examined Enico as an approach investigated for managing RA symptoms and disease activity. Outcomes frequently measured included:

  • Symptom Measurements: Studies examined measured changes in pain and stiffness levels in adults diagnosed with RA. Data from trials evaluated the potential to improve joint function, though results were not uniform across all studied populations.
  • Disease Activity: One line of investigation explored measurements of joint damage progression over various follow-up durations.

Combination Therapy

Some research has assessed the use of Enico alongside other conventional treatments. Findings suggested that the combination of treatments may be associated with changes in disease-specific laboratory markers when compared to the conventional treatment alone. Studies evaluated the observed tolerability profiles and outcomes of this combination treatment over a specific duration.


Important Considerations

The available clinical data can be reviewed with a healthcare provider to determine potential suitability. Consultation with a healthcare provider is suggested before making any changes to a current treatment plan or beginning a new one.

Frequently Asked Questions (FAQ)

Common questions about Enico (FAQ)


Q: Is Enico considered a long-term treatment option?

Its official designation is an essential nutrient and antioxidant. Regulatory documents note that using very high doses for prolonged periods is associated with specific safety concerns, particularly regarding the potential for increased bleeding tendency.


Q: Can Enico be taken with standard over-the-counter pain relievers?

The official product information indicates that high doses of Alpha-Tocopherol may potentiate the effect of antiplatelet agents, which include some over-the-counter pain medicines like aspirin. This combination may heighten the documented risk of bleeding. Co-administration with any non-prescription medicines should be discussed with a healthcare provider.


Q: Are there any specific foods or drinks that should be avoided while using Enico?

Official administration instructions mandate that Enico must be taken with a meal that contains fat to ensure proper systemic absorption. Separately, regulatory documents warn against using certain products that actively interfere with fat absorption, such as mineral oil or Orlistat, as this could reduce the effect of Enico. For specific questions regarding foods or drinks, consulting a healthcare provider is suggested.


Q: I've heard Enico can cause X side effect. How common is that side effect?

Official safety data groups adverse reactions by how often they occur. For example, diarrhea is listed as common with doses greater than 400 IU daily, while headache and fatigue are listed as uncommon. Official product labeling provides a comprehensive list and frequency for all reported effects. A healthcare provider can offer clarification on the frequency of a specific reported effect.


Q: What kind of studies were done to get Enico approved?

Enico (Alpha-Tocopherol) is classified as a vitamin preparation and nutritional supplement. The preparation is classified as a vitamin preparation and nutritional supplement, and its approval reflects its established role as an essential nutrient required for cellular protection.


Q: Is Enico safe for use in older adults (seniors)?

Studies in healthy older adults using common supplemental doses have generally not reported adverse effects on general health. Official guidelines do not set special restrictions or different Tolerable Upper Intake Levels for this population compared to other adults.


Q: Can individuals with a history of kidney issues use Enico?

The use of Alpha-Tocopherol in patients with certain health challenges, including Chronic Kidney Disease (CKD), has been a subject of investigation in clinical studies. Since overall nutrient metabolism can be complex in patients with kidney issues, the determination for use should be made by a healthcare professional.


Q: Is Enico safe for people who have mild liver problems?

Alpha-Tocopherol undergoes metabolism in the liver. Regulatory reviews have indicated that neither normal nor excessively high intakes are typically associated with causing liver injury. However, for people with pre-existing liver problems, appropriate use is typically determined by a healthcare provider.


Q: Does Enico interact with common supplements like vitamins or herbal remedies?

Yes, official drug interaction profiles indicate that Enico may interact with some other products. For instance, it may reduce the systemic exposure of oral ferric iron salts. Additionally, high doses may potentiate the effects of herbal products that have antithrombotic activity, such as garlic or ginkgo, thereby increasing the risk of bleeding.


Q: Is Enico known to cause tiredness or affect my ability to drive?

Official adverse reaction reports list fatigue (asthenia) and dizziness as uncommon effects associated with Enico, particularly when higher doses are used. Official guidance suggests that caution should be exercised regarding activities that require full attention, such as driving or operating machinery.


Q: Can Enico affect my blood sugar levels?

While regulatory drug labels do not list changes in blood sugar as a direct side effect, official safety information suggests that caution is warranted for patients with a pre-existing condition of diabetes. Concerns regarding metabolic effects are generally directed to a healthcare provider.


Q: Is it normal to feel a mild headache after starting Enico?

Official safety data lists headache as an uncommon adverse reaction associated with the use of Enico. If a severe or persistent headache occurs, evaluation by a healthcare professional is suggested.


Q: Are there any known interactions between Enico and alcohol consumption?

Official drug labels for Alpha-Tocopherol do not typically list a direct interaction with alcohol. However, it is recognized that alcohol consumption can generally affect overall nutritional status and the absorption of nutrients. Specific advice regarding alcohol use is best provided by a healthcare provider.


Q: Is Enico safe for use in children or teenagers?

Yes, Enico (Alpha-Tocopherol) is indicated for use in children and infants with Vitamin E deficiency. Dosing is weight- and age-based for pediatric groups, but high doses are specifically advised against for low birth weight premature infants. Use in teenagers generally follows the adult guidelines, within established upper limits for adolescents.


Q: What is the significance of the research evidence for Enico?

Clinical research has explored Alpha-Tocopherol for various health conditions, including its role in chronic inflammation. Regulatory bodies note that while the compound is an essential nutrient, there is generally no strong evidence to support a consistent preventative effect for major chronic diseases when used as a supplement.


Q: Does Enico require any special monitoring or regular blood tests?

Special monitoring is required for certain patients. Official safety information specifies that individuals concurrently taking oral anticoagulants (often called blood thinners, like warfarin) must have their International Normalized Ratio (INR) closely monitored. This is done to check for an increased risk of bleeding.


Q: Does Enico interact with birth control pills?

Some official drug interaction profiles mention that oral contraceptives may potentially lead to a lowering of plasma Vitamin E levels. Specific guidance regarding co-administration is generally sought from a healthcare provider.


Q: Are there any specific lab tests mentioned in the official documents for using Enico?

Yes, official documents specify the need for laboratory monitoring in certain patient groups. For those taking blood thinners, the International Normalized Ratio (INR) test is required to closely monitor coagulation and assess the potential for increased bleeding risk associated with high-dose Alpha-Tocopherol use.


Q: What is the general success rate of Enico in clinical trials?

Clinical trials examining Alpha-Tocopherol for various conditions have often yielded varied results and have not consistently supported a defined 'success rate' for chronic disease prevention. Outcomes assessed in studies, such as changes in pain or stiffness, have been noted to be non-uniform across all populations tested in research.


Q: Can Enico be taken if I am planning to become pregnant soon?

Alpha-Tocopherol is an essential nutrient needed during pregnancy and lactation. However, official regulatory documents state that high doses should only be taken if prescribed by a healthcare provider. Consulting a healthcare provider when planning to become pregnant is important to ensure appropriate intake levels.


Q: Is Enico considered a treatment or a way to manage symptoms?

Officially, Enico is classified as a nutritional supplement that provides the essential fat-soluble vitamin Alpha-Tocopherol. Its primary function is to support antioxidant defenses. However, clinical trials have also explored its role in managing symptoms of certain inflammatory conditions, such as Rheumatoid Arthritis.

How should Enico be stored and disposed of?

How to Store and Dispose of Enico?

The storage and disposal of Enico (Alpha-Tocopherol) must adhere strictly to regulatory requirements to maintain product stability and ensure public safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F); do not freeze.
Protection Keep the medicine protected from moisture and excessive heat in a dry place.
Packaging Store in the original container with the lid tightly closed at all times.
Child Safety Keep out of the sight and reach of children as a mandatory regulatory safety measure.

Disposal Instructions

Official disposal requires utilizing a drug take-back program whenever possible. If unavailable, the medicine should be mixed with an undesirable substance (such as coffee grounds) and placed in a sealed bag for disposal in household trash. It must not be flushed down the toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Enico found in:

A-Z Index: